Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapy. Found 481 abstracts

no pagination
Dash PK, Kaminski R, Bella R, Su H, Mathews S, Ahooyi TM, Chen C, Mancuso P, Sariyer R, Ferrante P, Donadoni M, Robinson JA, Sillman B, Lin Z, Hilaire JR, Banoub M, Elango M, Gautam N, Mosley RL, Poluektova LY, McMillan J, Bade AN, Gorantla S, Sariyer IK, Burdo TH, Young WB, Amini S, Gordon J, Jacobson JM, Edagwa B, Khalili K, Gendelman HE. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. Nat Commun. 2019 Jul 02;10(1):2753.   PMCID: PMC6606613
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet (London, England). 2019 Jan 05;393(10166):40-50.   PMCID: PMC6541928
Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hu J, Lacey NE, Gautam S, Le Gall JB, Yang X, Hocker JD, Escobar TM, He S, Dell'Orso S, Hawk NV, Kapoor V, Telford WG, Di Croce L, Muljo SA, Zhang Y, Sartorelli V, Gattinoni L. miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8(+) T cell fate. Nat Commun. 2019 May 14;10(1):2157.   PMCID: PMC6517388
Rouvinov K, Plimack ER, Zibelman M, Ghatalia P, Geynisman DM. Update on perioperative systemic therapy for urothelial carcinoma. Clinical advances in hematology & oncology : H&O. 2019 Mar;17(3):176-83.
Alberro JA, Ballester B, Deulofeu P, Fabregas R, Fraile M, Gubern JM, Janer J, Moral A, de Pablo JL, Penalva G, Puig P, Ramos M, Rojo R, Santesteban P, Serra C, Sola M, Solarnau L, Solsona J, Veloso E, Vidal S, Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, Nomura Y, Ohashi Y, Sakai K, Sugimachi K, Toi M, Tominaga T, Uchino J, Yoshida M, Coles CE, Haybittle JL, Mobus V, Leonard CF, Calais G, Garaud P, Collett V, Davies C, Delmestri A, Sayer J, Harvey VJ, Holdaway IM, Kay RG, Mason BH, Forbe JF, Franci PA, Wilcken N, Balic M, Bartsch R, Fesl C, Fitzal F, Fohler H, Gnant M, Greil R, Jakesz R, Marth C, Mlineritsch B, Pfeiler G, Singer CF, Steger GG, Stoger H, Canney P, Yosef HM, Focan C, Peek U, Oates GD, Powell J, Durand M, Mauriac L, Di Leo A, Dolci S, Larsimont D, Nogaret JM, Philippson C, Piccart MJ, Masood MB, Parker D, Price JJ, Lindsay MA, Mackey J, Martin M, Hupperets P, Bates T, Blamey RW, Chetty U, Ellis IO, Mallon E, Morgan DA, Patnick J, Pinder S, Lohrisch C, Nichol A, Bartlett JM, Bramwell VH, Chen BE, Chia SK, Gelmon K, Goss PE, Levine MN, Parulekar W, Pater JL, Pritchard KI, Shepherd LE, Tu D, Whelan T, Berry D, Broadwater G, Cirrincione C, Muss H, Norton L, Weiss RB, Abu-Zahara HT, Karpov A, Portnoj SL, Bowden S, Brookes C, Dunn J, Fernando I, Lee M, Poole C, Rea D, Spooner D, Barrett-Lee PJ, Manse RE, Monypenny IJ, Gordon NH, Davis HL, Cuzick J, Sestak I, Lehingue Y, Romestaing P, Dubois JB, Delozier T, Griffon B, Lesec'H JM, Mustacchi G, Petruzelka L, Pribylova O, Owen JR, Meier P, Shan Y, Shao YF, Wang X, Zhao DB, Howell A, Swindell R, Albano J, de Oliveira CF, Gervasio H, Gordilho J, Ejlertsen B, Jensen MB, Mouridsen H, Gelman RS, Harris JR, Hayes D, Henderson C, Shapiro CL, Christiansen P, Ejlertsen B, Ewertz M, Jensen MB, Mouridsen HT, Fehm T, Trampisch HJ, Dalesio O, de Vries EG, Rodenhuis S, van Tinteren H, Comis RL, Davidson NE, Gray R, Robert N, Sledge G, Solin LJ, Sparano JA, Tormey DC, Wood W, Cameron D, Chetty U, Dixon JM, Forrest P, Jack W, Kunkler I, Rossbach J, Klijn JG, Treurniet-Donker AD, van Putten WL, Rotmensz N, Veronesi U, Viale G, Bartelink H, Bijker N, Bogaerts J, Cardoso F, Cufer T, Julien JP, Poortmans PM, Rutgers E, van de Velde CJ, Cunningham MP, Huovinen R, Joensuu H, Costa A, Bonadonna G, Gianni L, Valagussa P, Goldstein LJ, Bonneterre J, Fargeot P, Fumoleau P, Kerbrat P, Lupors E, Namer M, Carrasco E, Martin M, Segui MA, Eierman W, Hilfrich J, Jonat W, Kaufmann M, Kreienberg R, Schumacher M, Bastert G, Rauschecker H, Sauer R, Sauerbrei W, Schauer A, Schumacher M, Blohmer JU, Costa SD, Eidtmann H, Gerber B, Jackisch C, Loib S, von Minckwitz G, de Schryver A, Vakaet L, Belfiglio M, Nicolucci A, Pellegrini F, Pirozzoli MC, Sacco M, Valentini M, McArdle CS, Smith DC, Stallard S, Dent DM, Gudgeon CA, Hacking A, Murray E, Panieri E, Werner ID, De Salvo GL, Del Bianco P, Zavagno G, Leone B, Vallejo CT, Zwenger A, Galligioni E, Lopez M, Erazo A, Medina JY, Horiguchi J, Takei H, Fentiman IS, Hayward JL, Rubens RD, Skilton D, Scheurlen H, Kaufmann M, Sohn HC, Untch M, Dafni U, Markopoulos C, Bamia C, Fountzilas G, Koliou GA, Manousou K, Mavroudis D, Klefstrom P, Blomqvist C, Saarto T, Gallen M, Canavese G, Tinterri C, Margreiter R, de Lafontan B, Mihura J, Roche H, Asselain B, Salmon RJ, Vilcoq JR, Brain E, de La Lande B, Mouret-Fourme E, Andre F, Arriagada R, Delaloge S, Hill C, Koscienly S, Michiels S, Rubino C, A'Hern R, Bliss J, Ellis P, Kilburn L, Yarnold JR, Martin M, Benraadt J, Kooi M, van de Velde AO, van Dongen JA, Vermorken JB, Castiglione M, Coates A, Colleoni M, Collins J, Forbes J, Gelbe RD, Goldhirsch A, Lindtner J, Price KN, Regan MM, Rudenstam CM, Senn HJ, Thuerlimann B, Bliss JM, Chilvers CE, Coombes RC, Hall E, Marty M, Buyse M, Possinger K, Schmid P, Untch M, Wallwiener D, Foster L, George WD, Stewart HJ, Stroner P, Borovik R, Hayat H, Inbar MJ, Peretz T, Robinson E, Camerini T, Formelli F, Martelli G, Di Mauro MG, Valagussa P, Perrone F, Amadori D, Martoni A, Pannuti F, Camisa R, Musolino A, Passalacqua R, Iwata H, Shien T, Abe O, Ikeda T, Inokuchi K, Kikuchi K, Sawa K, Sonoo H, Sadoon M, Tulusan AH, Kohno N, Miyashita M, Takao S, Ahn JH, Jung KH, Korzeniowski S, Skolyszewski J, Ogawa M, Yamashita J, Bastiaannet E, Liefers GJ, van de Velde CJ, Christiaens R, Neven P, Paridaens R, Van den Bogaert W, Gazet JC, Corcoran N, Deshpande N, di Martino L, Douglas P, Hacking A, Host H, Lindtner A, Notter G, Bryant AJ, Ewing GH, Firth LA, Krushen-Kosloski JL, Nissen-Meyer R, Anderson H, Killander F, Malmstrom P, Ryden L, Arnesson LG, Carstense J, Dufmats M, Fohlin H, Nordenskjold B, Soderberg M, Sundqvist M, Carpenter TJ, Murray N, Royle GT, Simmonds PD, Albain K, Barlow W, Crowley J, Hayes D, Gralow J, Hortobagyi G, Livingston R, Martino S, Osborne CK, Ravdin PM, Bergh J, Bondesso T, Celebiogl F, Dahlberg K, Fornander T, Fredriksson I, Frisell J, Goransson E, Iiristo M, Johansson U, Lenner E, Lofgren L, Nikolaidis P, Perbeck L, Rotstein S, Sandelin K, Skoog L, Svane G, af Trampe E, Wadstrom C, Janni W, Castiglione M, Goldhirsch A, Maibach R, Senn HJ, Thurlimann B, Bartlett JM, Bastiaannet E, Hadji P, Hozumi J, Rea D, van de Velde CJ, Holli K, Rouhento K, Safra T, Brenner H, Hercbergs A, Yoshimoto M, Paterson AH, Pritchard KI, Fyles A, Meakin JW, Panzarella T, Pritchard KI, Bahi J, Delaloge S, Lemonnier J, Martin AL, Reid M, Spittle M, Bishop H, Bundred NJ, Cuzick J, Ellis IO, Fentiman IS, Forbes JF, Forsyth S, George WS, Pinder SE, Sestak I, Deutsch GP, Gray R, Kwong DL, Pai VR, Peto R, Senanayake F, Boccardo F, Rubagotti A, Baum M, Forsyth S, Hackshaw A, Houghton J, Ledermann J, Monson K, Tobias JS, Carlomagno C, De Laurentiis M, De Placido S, Schem C, Williams L, Bell R, Cameron D, Coleman RE, Dodwell D, Hinsley S, Marshall HC, Hayes D, Pierce LJ, Basso SM, Lumachi F, Solomayer E, Coleman RE, Horsman JM, Lester J, Winter MC, Buzdar AU, Hsu L, Love RR, Ahlgren J, Garmo H, Holmberg L, Lindman H, Warnberg F, Asmar L, Jones SE, Aft R, Gluz O, Harbeck N, Liedtke C, Nitz U, Litton A, Wallgren A, Karlsson P, Linderholm BK, Chlebowski RT, Caffier H, Brufsky AM, Coleman RE, Llombart HA, Ebctcg, Ebctcg, Grocta Trialists. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncology. 2018 Jan;19(1):27-39.
Bass SB, Jessop A, Maurer L, Gashat M, Al Hajji M, Gutierrez M. Mapping the Barriers and Facilitators of HCV Treatment Initiation in Methadone Maintenance Therapy Patients: Implications for Intervention Development. Journal of health communication. 2018 Jan;23(1):117-27.
Chhatre S, Jefferson A, Cook R, Meeker CR, Kim JH, Hartz KM, Wong YN, Caruso A, Newman DK, Morales KH, Jayadevappa R. Patient-centered recruitment and retention for a randomized controlled study. Trials. 2018 Mar 27;19(1):205.   PMCID: PMC5870194
Edwards DC, Cahn DB, Smaldone MC, Kutikov A. Use of administrative data for comparative effectiveness research in the treatment of non-prostate genitourinary malignancies. Urol Oncol. 2018 Apr;36(4):193-212.
Joshi SS, Handorf EA, Zibelman M, Plimack ER, Uzzo RG, Kutikov A, Smaldone MC, Geynisman DM. Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis. Eur Urol. 2018 Sep;74(3):387-93.
Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. Jama. 2018 Mar 06;319(9):896-905.   PMCID: PMC5885899
Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero MH, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O'Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2018 Jun;21(6):742-7.
Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero MH, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O'Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value Health. 2018 Jun;21(6):742-7.
Lyu Z, Kang L, Buuh ZY, Jiang D, McGuth JC, Du J, Wissler HL, Cai W, Wang RE. A Switchable Site-Specific Antibody Conjugate. ACS chemical biology. 2018 Apr 20;13(4):958-64.   PMCID: PMC5910183
Roach M, Moughan J, Lawton CA, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR, Shipley WU, Sandler HM. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. Lancet Oncol. 2018 Nov;19(11):1504-15.   PMCID: PMC6540797
Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2018 Jan;41(1):59-64.   PMCID: PMC4769977
Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, Le QT, Raben D, Strome SE, Lynn J, Malik S. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. 2017 Apr;123(7):1259-71.   PMCID: PMC5705038
Boland PM, Meyer JE, Berger AC, Cohen SJ, Neuman T, Cooper HS, Olszanski AJ, Davey M, Cheng JD, Lebenthal A, Burtness BA, Scott WJ, Astsaturov IA. Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection. Am J Clin Oncol. 2017 Aug;40(4):393-8.   PMCID: PMC5026539
Chambers SK, Occhipinti S, Foley E, Clutton S, Legg M, Berry M, Stockler MR, Frydenberg M, Gardiner RA, Lepore SJ, Davis ID, Smith DP. Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial. J Clin Oncol. 2017 Jan 20;35(3):291-7.
Churilla TM, Egleston B, Bleicher R, Dong Y, Meyer J, Anderson P. Disparities in the Local Management of Breast Cancer in the US according to Health Insurance Status. Breast J. 2017 Mar;23(2):169-76.
Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS. Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2017 Jun;18(6):779-91.   PMCID: PMC5715461
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapy

therapy Treatment Outcome Middle Aged methods Male therapeutic use adverse effects pathology Aged Female United States administration & dosage Adult mortality immunology Neoplasm Staging diagnosis surgery 80 and over Aged Combined Modality Therapy Antineoplastic Agents Retrospective Studies drug therapy Neoplasms metabolism Antineoplastic Combined Chemotherapy Protocols Time Factors Drug Administration Schedule Disease-Free Survival Registries Prostatic Neoplasms Chemoradiotherapy virology Adoptive Transfer Drug-Related Side Effects and Adverse Reactions Neoplasm Invasiveness Risk Assessment United States Food and Drug Administration Patient Reported Outcome Measures Comparative Effectiveness Research analogs & derivatives Attitudes Health Knowledge-Practice Immunologic Factors Pro-ctcae Young Adult Molecular Targeted Therapy genetics etiology Survival Analysis drug safety Critical Pathways Intensity-Modulated Radiotherapy Carboplatin Paclitaxel Medical Oncology Cisplatin Adenocarcinoma Neoplasm Grading psychology Surveys and Questionnaires Kaplan-Meier Estimate statistics & numerical data Patient Selection Neoplasm Metastasis Mice oncology tolerability patient-reported outcomes Leuprolide radiation therapy Disease Progression blood Hepatitis C head and neck cancer Medicaid Flutamide Breast Neoplasms Switch Genes High-Volume Hospitals Local Neoplasm Recurrence CD8-Positive T-Lymphocytes Fallopian Tube Neoplasms Cost of Illness HIV-1 Carcinoma transplantation Opiate Substitution Treatment Binding Sites SEER Program Clinical Trials as Topic Health Services Accessibility Remote Consultation Canada Mindfulness Pancreatic Neoplasms Incidence Prostatectomy Piperidines Renal cell carcinoma breast cancer Patient Dropouts Datasets as Topic Follow-Up Studies Randomized Controlled Trials as Topic Urothelium Patient Education as Topic Anti-HIV Agents Insurance Coverage Viral DNA Psychological Adaptation Experimental Melanoma Cancer survival Group Psychotherapy physiopathology survival Neoplastic Gene Expression Regulation Bevacizumab Radiotherapy Polycomb Repressive Complex 2 Urinary Bladder Neoplasms Kidney Neoplasms Papillomavirus Infections recurrence Quinazolines Perioperative Care Cellular Senescence Prognosis Adolescent human papillomavirus Fluorouracil Predictive Value of Tests Gene Editing Knockout Mice Androgen Antagonists Health Insurance Cytoreduction Surgical Procedures Phenylalanine Peptides National Cancer Institute (US) radiotherapy Hematologic Diseases Quality of Life Goserelin physiology Drug Dose-Response Relationship Philadelphia Cetuximab Immunotherapy Risk Factors Antibodies
Last updated on Friday, December 06, 2019